We are live on ! Find out more
MLICM

Metropolitan Life Insurance Company (MetLife) Portfolio holdings

AUM $328M
1-Year Est. Return 9.77%
This Fund
S&P 500
This Quarter Est. Return
+11.43%
1 Year Est. Return
+9.77%
3 Year Est. Return
+50.33%
5 Year Est. Return
+74.21%
10 Year Est. Return
+345.05%
AUM
$7.36B
AUM Growth
+$457M
Cap. Flow
-$178M
Cap. Flow %
-2.42%
Top 10 Hldgs %
26.1%
Holding
2,906
New
66
Increased
422
Reduced
1,573
Closed
124

Sector Composition

Rank Sector Weight
1 Technology 25.69%
2 Consumer Discretionary 12.47%
3 Healthcare 12.1%
4 Financials 11.43%
5 Communication Services 8.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FCX icon
151
Freeport-McMoran
FCX
$96.9B
$7.78M 0.11%
186,397
-4,429
-2% -$168K
REGN icon
152
Regeneron Pharmaceuticals
REGN
$82.2B
$7.74M 0.11%
12,257
-287
-2% -$176K
NXPI icon
153
NXP Semiconductors
NXPI
$58.9B
$7.7M 0.1%
33,825
-1,170
-3% -$249K
FTNT icon
154
Fortinet
FTNT
$118B
$7.7M 0.1%
107,170
-2,490
-2% -$164K
APD icon
155
Air Products & Chemicals
APD
$67.7B
$7.7M 0.1%
25,301
-511
-2% -$150K
FIS icon
156
Fidelity National Information Services
FIS
$21.6B
$7.6M 0.1%
69,602
-3,095
-4% -$350K
APH icon
157
Amphenol
APH
$210B
$7.59M 0.1%
173,528
-4,174
-2% -$169K
A icon
158
Agilent Technologies
A
$41.9B
$7.5M 0.1%
46,959
-1,133
-2% -$176K
VWO icon
159
Vanguard FTSE Emerging Markets ETF
VWO
$126B
$7.4M 0.1%
149,600
-7,200
-5% -$363K
DG icon
160
Dollar General
DG
$26.4B
$7.39M 0.1%
31,327
-713
-2% -$157K
VRTX icon
161
Vertex Pharmaceuticals
VRTX
$133B
$7.36M 0.1%
33,498
-1,335
-4% -$260K
MCHP icon
162
Microchip Technology
MCHP
$43.1B
$7.32M 0.1%
84,049
-731
-0.9% -$59.1K
IQV icon
163
IQVIA
IQV
$39.8B
$7.32M 0.1%
25,931
-765
-3% -$199K
O icon
164
Realty Income
O
$59.2B
$7.3M 0.1%
101,975
+27,950
+38% +$1.92M
D icon
165
Dominion Energy
D
$59.8B
$7.27M 0.1%
92,499
-2,546
-3% -$192K
MSCI icon
166
MSCI
MSCI
$40.9B
$7.27M 0.1%
11,858
-299
-2% -$188K
MAR icon
167
Marriott International
MAR
$92.5B
$7.26M 0.1%
43,918
-1,061
-2% -$167K
FISV
168
Fiserv Inc
FISV
$27.4B
$7.26M 0.1%
69,902
-1,278
-2% -$132K
COF icon
169
Capital One
COF
$136B
$6.99M 0.1%
48,168
-4,245
-8% -$656K
BSX icon
170
Boston Scientific
BSX
$74.5B
$6.91M 0.09%
162,775
-4,611
-3% -$194K
PGR icon
171
Progressive
PGR
$121B
$6.86M 0.09%
66,864
-1,128
-2% -$108K
NOC icon
172
Northrop Grumman
NOC
$82B
$6.83M 0.09%
17,633
-700
-4% -$261K
HUM icon
173
Humana
HUM
$46.7B
$6.82M 0.09%
14,704
-276
-2% -$122K
PAYX icon
174
Paychex
PAYX
$42.8B
$6.75M 0.09%
49,437
-1,143
-2% -$141K
WELL icon
175
Welltower
WELL
$166B
$6.73M 0.09%
78,461
+618
+0.8% +$51.5K

Similar funds

Metropolitan Life Insurance Company (MetLife)'s Q4 2021 Portfolio in Review

As of Q4 2021, Metropolitan Life Insurance Company (MetLife) held 2,906 positions worth $7.36B, up 6.6% from $6.9B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Metropolitan Life Insurance Company (MetLife)'s Q4 2021 filing shows 66 new, 422 increased, 1,573 reduced and 124 closed positions. Its largest new stake was Kyndryl: 32,951 shares worth $596K. The largest sale was iShares Russell 1000 Growth ETF, an estimated $18.3M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 24% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Metropolitan Life Insurance Company (MetLife)'s largest Q4 2021 buy was Kyndryl: 32,951 shares worth $596K.
  • Metropolitan Life Insurance Company (MetLife) added most to State Street SPDR S&P 500 ETF Trust in Q4 2021, an estimated $34.8M increase.
  • Metropolitan Life Insurance Company (MetLife)'s biggest Q4 2021 reduction was iShares Russell 1000 Growth ETF, cutting an estimated $18.3M.
  • Metropolitan Life Insurance Company (MetLife) fully exited Kansas City Southern in Q4 2021, selling an estimated $3.18M.
  • Metropolitan Life Insurance Company (MetLife)'s ten largest holdings make up 26% of its $7.36B portfolio in Q4 2021.
  • Metropolitan Life Insurance Company (MetLife) opened 66 new positions and closed 124 in Q4 2021.
  • Metropolitan Life Insurance Company (MetLife)'s portfolio value rose 6.6% quarter-over-quarter to $7.36B.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q4 2021, filed 15 Feb 2022.